These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 29229109)

  • 1. Evaluation and quantification of treatment preferences for patients with asthma or COPD using discrete choice experiment surveys.
    Svedsater H; Leather D; Robinson T; Doll H; Nafees B; Bradshaw L
    Respir Med; 2017 Nov; 132():76-83. PubMed ID: 29229109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient preferences for dry powder inhaler attributes in asthma and chronic obstructive pulmonary disease in France: a discrete choice experiment.
    Hawken N; Torvinen S; Neine ME; Amri I; Toumi M; Aballéa S; Plich A; Roche N
    BMC Pulm Med; 2017 Jul; 17(1):99. PubMed ID: 28683805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Burden of asthma and COPD overlap (ACO) in Taiwan: a nationwide population-based study.
    Shantakumar S; Pwu RF; D'Silva L; Wurst K; Kuo YW; Yang YY; Juan YC; Chan KA
    BMC Pulm Med; 2018 Jan; 18(1):16. PubMed ID: 29368608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Asthma and COPD: guidance in the jungle of inhalative drugs].
    Hering T
    MMW Fortschr Med; 2015 May; 157(10):59, 61-2. PubMed ID: 26019099
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment trends in patients with asthma-COPD overlap syndrome in a COPD cohort: findings from a real-world survey.
    Ding B; Small M
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1753-1763. PubMed ID: 28670116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Respiratory pharmacotherapy use in patients newly diagnosed with chronic obstructive pulmonary disease in a primary care setting in the UK: a retrospective cohort study.
    Wurst KE; Shukla A; Muellerova H; Davis KJ
    COPD; 2014 Sep; 11(5):521-30. PubMed ID: 24945236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maintenance inhaler therapy preferences of patients with asthma or chronic obstructive pulmonary disease: a discrete choice experiment.
    Tervonen T; Hawken N; Hanania NA; Martinez FJ; Heidenreich S; Gilbert I
    Thorax; 2020 Sep; 75(9):735-743. PubMed ID: 32631932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exacerbations and healthcare resource utilization among COPD patients in a Swedish registry-based nation-wide study.
    Johansson G; Mushnikov V; Bäckström T; Engström A; Khalid JM; Wall J; Hoti F
    BMC Pulm Med; 2018 Jan; 18(1):17. PubMed ID: 29370846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Why choose tiotropium for my patient? A comprehensive review of actions and outcomes versus other bronchodilators.
    Halpin DM; Kaplan AG; Russell RK
    Respir Med; 2017 Jul; 128():28-41. PubMed ID: 28610667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of poor asthma control among asthma patients treated with inhaled corticosteroids plus long-acting β
    Pavord ID; Mathieson N; Scowcroft A; Pedersini R; Isherwood G; Price D
    NPJ Prim Care Respir Med; 2017 Mar; 27(1):17. PubMed ID: 28270657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating Patient Preferences of Maintenance Therapy for the Treatment of Chronic Obstructive Pulmonary Disease: A Discrete Choice Experiment in the UK, USA and Germany.
    Lewis HB; Schroeder M; Gunsoy NB; Janssen EM; Llewellyn S; Doll HA; Jones PW; Ismaila AS
    Int J Chron Obstruct Pulmon Dis; 2020; 15():595-604. PubMed ID: 32256060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The reasons for triple therapy in stable COPD patients in Japanese clinical practice.
    Miyazaki M; Nakamura H; Takahashi S; Chubachi S; Sasaki M; Haraguchi M; Terai H; Ishii M; Fukunaga K; Tasaka S; Soejima K; Asano K; Betsuyaku T;
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1053-9. PubMed ID: 26082629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics, disease burden and costs of COPD patients in the two years following initiation of long-acting bronchodilators in UK primary care.
    Punekar YS; Landis SH; Wurst K; Le H
    Respir Res; 2015 Nov; 16():141. PubMed ID: 26572740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GOLD 2017 treatment pathways in 'real life': An analysis of the DACCORD observational study.
    Worth H; Buhl R; Criée CP; Kardos P; Lossi NS; Vogelmeier CF
    Respir Med; 2017 Oct; 131():77-84. PubMed ID: 28947047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triple inhaled therapy for chronic obstructive pulmonary disease.
    Montuschi P; Malerba M; Macis G; Mores N; Santini G
    Drug Discov Today; 2016 Nov; 21(11):1820-1827. PubMed ID: 27452453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of medication adherence/persistence for asthma and chronic obstructive pulmonary disease in the United Kingdom.
    Covvey JR; Mullen AB; Ryan M; Steinke DT; Johnston BF; Wood FT; Boyter AC
    Int J Clin Pract; 2014 Oct; 68(10):1200-8. PubMed ID: 24797899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study on medical utilization and costs of chronic obstructive pulmonary disease with good lung function.
    Lim JU; Kim K; Kim SH; Lee MG; Lee SY; Yoo KH; Lee SH; Jung KS; Rhee CK; Hwang YI
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2711-2721. PubMed ID: 28979113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Life Impact and Treatment Preferences of Individuals with Asthma and Chronic Obstructive Pulmonary Disease: Results from Qualitative Interviews and Focus Groups.
    Svedsater H; Roberts J; Patel C; Macey J; Hilton E; Bradshaw L
    Adv Ther; 2017 Jun; 34(6):1466-1481. PubMed ID: 28536998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the disease phenotypes.
    Hizawa N
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1093-102. PubMed ID: 26089659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The burden of chronic obstructive pulmonary disease associated with maintenance monotherapy in the UK.
    Edwards SC; Fairbrother SE; Scowcroft A; Chiu G; Ternouth A; Lipworth BJ
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2851-2858. PubMed ID: 27920512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.